Is It Time To Reassess Cabot (CBT) After Its Recent Share Price Strength?

Cabot Corporation

Cabot Corporation

CBT

0.00

  • If you are wondering whether Cabot is trading at an attractive price today, or if the recent enthusiasm already reflects its value, this breakdown will help you put the current share price in context.
  • Cabot's stock recently closed at US$82.41, with returns of 8.8% over the past week, 10.8% over the past month, 22.9% year to date and 15.7% over the past year, which can influence how you think about upside and risk.
  • Recent coverage around Cabot has focused on giving investors evergreen context on the stock, highlighting how it fits within the broader materials sector and what current expectations imply for the share price. This refresher is timely for anyone reassessing positions after the recent price moves.
  • On Simply Wall St's valuation checks, Cabot scores 3 out of 6. You will see how different methods assess whether that current price looks stretched or reasonable, and later in the article you will see an approach that can help you connect the valuation to the bigger investment story.

Approach 1: Cabot Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a stock could be worth by projecting future cash flows and discounting them back to today, so you can compare that value to the current share price.

For Cabot, the model uses a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month Free Cash Flow is around $415.6 million. Analyst inputs and extrapolated estimates point to projected Free Cash Flow of about $292.2 million in 2035, with interim projections such as $281 million in 2026 and $256 million in 2028, all in $.

Discounting these cash flows back to today gives an estimated intrinsic value of about $99.80 per share. Compared with the recent share price of $82.41, the model output suggests Cabot is trading at a 17.4% discount on this DCF view.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Cabot is undervalued by 17.4%. Track this in your watchlist or portfolio, or discover 44 more high quality undervalued stocks.

CBT Discounted Cash Flow as at May 2026
CBT Discounted Cash Flow as at May 2026

Approach 2: Cabot Price vs Earnings (P/E)

For profitable companies, the P/E ratio is a useful quick check because it ties what you pay directly to the earnings the business is already generating. Investors usually expect higher P/E ratios when they see stronger earnings growth potential or lower perceived risk, and lower P/E ratios when growth expectations or confidence are more muted.

Cabot currently trades on a P/E of 15.37x. That sits below the Chemicals industry average P/E of 28.08x and also below the peer group average of 21.19x, which tells you the stock is currently valued at a lower earnings multiple than many sector peers.

Simply Wall St also uses a proprietary “Fair Ratio” for P/E, which estimates what Cabot’s P/E might be given its earnings growth profile, industry, profit margins, market cap and risk characteristics. This Fair Ratio aims to be more tailored than a simple peer or industry comparison because it adjusts for company specific fundamentals rather than relying only on broad averages. In this case, the Fair Ratio is not available, so it is not possible to conclude whether the current 15.37x P/E suggests Cabot is overvalued, undervalued or about right on this measure.

Result: ABOUT RIGHT

NYSE:CBT P/E Ratio as at May 2026
NYSE:CBT P/E Ratio as at May 2026

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Cabot Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so Narratives are worth a look because they let you connect your view of Cabot’s business to a financial forecast and a fair value that you can compare with the current share price.

A Narrative is simply your story about a company, written into numbers, where your expectations for future revenue, earnings and margins feed into an estimated fair value rather than sitting as vague opinions.

On Simply Wall St’s Community page, Narratives are available as a straightforward tool used by millions of investors, helping you see how a company’s story links to a forecast and then to a fair value that updates as new information such as news or earnings arrives.

For Cabot, one investor might build a Narrative that assumes stronger cash generation and arrives at a higher fair value. Another might plug in more cautious assumptions and land on a lower fair value. Comparing each Narrative’s fair value with today’s price can help you decide whether Cabot fits your own framework for a potential investment decision.

Do you think there's more to the story for Cabot? Head over to our Community to see what others are saying!

NYSE:CBT 1-Year Stock Price Chart
NYSE:CBT 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.